Intermittent Chemotherapy of Experimental Leprosy in Mice

M. J. Colston Life Sciences Division, SRI International, St. George's Hospital Medical School, Menlo Park, California 94025, United Kingdom

Search for other papers by M. J. Colston in
Current site
Google Scholar
PubMed
Close
,
G. R. F. Hilson Life Sciences Division, SRI International, St. George's Hospital Medical School, Menlo Park, California 94025, United Kingdom

Search for other papers by G. R. F. Hilson in
Current site
Google Scholar
PubMed
Close
, and
R. D. Lancaster Life Sciences Division, SRI International, St. George's Hospital Medical School, Menlo Park, California 94025, United Kingdom

Search for other papers by R. D. Lancaster in
Current site
Google Scholar
PubMed
Close
Restricted access

In this study we assess the degree of prolonged bacteriostasis of Mycobacterium leprae after temporary exposure to ethionamide or thiacetazone, and relate this to their efficacy when administered intermittently to mice with experimental leprosy infections. The results show that temporary exposure of M. leprae to either of these drugs results in a prolonged bacteriostatic effect, but that efficacy is rapidly lost as the interval between doses is increased. Using the mouse foot pad system, growth of M. leprae is not inhibited by thiacetazone when the frequency of administration is less than three times weekly. When ethionamide is administered once weekly, growth of M. leprae is inhibited but bactericidal activity is lost. When ethionamide is administered in combination with continuous dapsone therapy, either continuously or three times weekly, the bactericidal activity of the drug combination is greater than when either drug is administered alone. However, when ethionamide is administered once weekly in combination with continuous dapsone treatment, the bactericidal effect is identical to that when dapsone is given alone: that is, ethionamide makes no contribution to the combination.

Author Notes

Save